Carcinomes sarcomatoïdes, hors pneumoblastomes
Bilan pré-thérapeutique

Les principes du bilan pré-thérapeutique sont les mêmes que pour les autres carcinomes bronchiques non à petites cellules. Il existe un hypermétabolisme élevé en tomographie par émission de positons au F18-déoxyglucose. Les métastases de localisation inhabituelle sont fréquentes (1,4,12–14,27). Cet hypermétabolisme serait plus intense en cas de carcinome pléomorphe (28–30)



1. Travis WD, World Health Organization, International Agency for Research on Cancer, International Association for the Study of Lung Cancer, International Academy of Pathology, editors. Pathology and genetics of tumours of the lung, pleura, thymus and heart. Lyon : Oxford: IARC Press, Oxford University Press (distributor); 2004. 344 p. (World Health Organization classification of tumours).

4. Nakajima M, Kasai T, Hashimoto H, Iwata Y, Manabe H. Sarcomatoid carcinoma of the lung: a clinicopathologic study of 37 cases. Cancer. 1999 Aug 15;86(4):608–16.

12. Ro JY, Chen JL, Lee JS, Sahin AA, Ordóñez NG, Ayala AG. Sarcomatoid carcinoma of the lung. Immunohistochemical and ultrastructural studies of 14 cases. Cancer. 1992 Jan 15;69(2):376–86.

13. Chang YL, Lee YC, Shih JY, Wu CT. Pulmonary pleomorphic (spindle) cell carcinoma: peculiar clinicopathologic manifestations different from ordinary non-small cell carcinoma. Lung Cancer Amst Neth. 2001 Oct;34(1):91–7.

14. Cabarcos A, Gomez Dorronsoro M, Lobo Beristain JL. Pulmonary carcinosarcoma: a case study and review of the literature. Br J Dis Chest. 1985 Jan;79(1):83–94.

27. Shi B, Gaebelein G, Hildebrandt B, Weichert W, Glanemann M. Adult jejunojejunal intussusception caused by metastasized pleomorphic carcinoma of the lung: report of a case. Surg Today. 2009;39(11):984–9.

28. Ito K, Oizumi S, Fukumoto S, Harada M, Ishida T, Fujita Y, et al. Clinical characteristics of pleomorphic carcinoma of the lung. Lung Cancer Amst Neth. 2010 May;68(2):204–10.

29. Cheran SK, Nielsen ND, Patz EF. False-negative findings for primary lung tumors on FDG positron emission tomography: staging and prognostic implications. AJR Am J Roentgenol. 2004 May;182(5):1129–32.

30. Park JS, Lee Y, Han J, Kim HK, Choi YS, Kim J, et al. Clinicopathologic outcomes of curative resection for sarcomatoid carcinoma of the lung. Oncology. 2011;81(3–4):206–13.